STUDY

Prescription hair-loss drugs work; store-bought products got only a first look

“Relative Efficacy of Conventional Monotherapies and Select Nonconventional, Over-the-Counter Products for Male Androgenetic Alopecia: A Network Meta-Analysis Study.” Gupta AK et al. Journal of Cosmetic Dermatology. October 2025

Gupta AK et al. · Journal of Cosmetic Dermatology · October 2025

Network meta-analysis
The finding

This analysis pooled 24 trials in men. It confirmed that oral dutasteride, topical or oral minoxidil, and oral or topical finasteride grow hair. It also gave a first look at how some over-the-counter products, such as topical melatonin and rosemary oil, compare.

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Network meta-analysis. Treatments are compared by linking trials through shared groups such as placebo, so treatments that were never tested head to head can still be ranked.
At a glance

Who was studied and for how long

Evidence
24 trials
Found by a systematic search of PubMed and Scopus (to April 2025)
Compared
8 standard + 7 over-the-counter products
Alone, not combined
Who
Men with pattern hair loss
Androgenetic alopecia
Measured
24 weeks
Change in total hair density
What they did

How the study worked

1. SearchThe authors searched PubMed and Scopus for trials in men.
2. LinkThey linked treatments through shared comparison groups.
3. CompareA statistical model estimated the difference in hair density for each treatment.
What they found

The results

Prescription and conventional treatments

The network supported the effects of established options such as oral dutasteride, minoxidil and finasteride on hair density.

Selected over-the-counter options

The analysis also included products such as topical melatonin and rosemary oil. The comparison depended on the available formulations and trials.

The main outcome was total hair density at 24 weeks. Many estimates combine indirect comparisons and cannot substitute for a direct trial of the same doses and formulations.
How much to trust it

Strengths and limits

Strengths

  • Includes both standard drugs and popular OTC products
  • Uses one clear outcome: hair density at 24 weeks
  • Quality of each study was assessed

Limits

  • Men only
  • Many comparisons are indirect
  • The abstract does not give the size of each effect
  • Search ended April 2025
Moderate confidence. A recent, broad look, but built on indirect comparisons.
What it means for you

The takeaway

Standard drugs confirmed

Oral dutasteride, minoxidil and finasteride all raised hair density in men. A few OTC products were also compared with the standard drugs.

OTC products were compared mostly in small trials. Talk with your dermatologist before changing treatment.

Pages that cite this study

Read more on Dermapedia

Terms in this study

Words worth knowing

Network meta-analysis

A method that ranks several treatments by linking many trials together.

Monotherapy

One treatment used alone.

Hair density

The number of hairs in a set area of scalp.

Original source

Gupta AK, Bamimore MA, Talukder M. Relative Efficacy of Conventional Monotherapies and Select Nonconventional, Over-the-Counter Products for Male Androgenetic Alopecia: A Network Meta-Analysis Study.. J Cosmet Dermatol. 2025;24(10):e70483.

PMID 41051009